VMG Health's 2017 Intellimarker Multi-Specialty ASC Study included statistics on ASC revenue per case for gastroenterology.
GI & Endoscopy
The Canadian Task Force on Preventive Health Care's decision to exclude baby boomers from their new guidelines concerning hepatitis C virus screenings is creating a ruckus throughout the medical community, MedpageToday reports.
A study, published in Inflammatory Bowel Diseases, examined what factors inflammatory bowel disease patients respond to in anti-tumor necrosis factor therapy.
Numerate entered into an agreement with Takeda to use its artificial intelligence engines to develop clinical candidates in multiple specialties.
Absolute Report analysts expect the gastrointestinal endoscopy device market to grow significantly through 2020.
Level Ex CEO and Founder Sam Glassenberg is working to address how physicians can virtually practice their craft.
Andrew Riegel, MD, is a gastroenterologist at Fort Walton Beach, Fla.-based Emerald Coast Gastroenterology.
After early findings were "not sufficient to meet efficacy," XBiotech discontinued its phase III study of its novel candidate antibody therapy for colorectal cancer.
A national study is aiming to quantify the financial hardship cancer treatment places on patients, The Minnesota StarTribune reports.
A study, published in the Journal of the American Geriatrics Society, examined if proton pump inhibitor use increased the likelihood of cognitive impairment, dementia and Alzheimer's disease.
